| Income Statement |
| Total Revenue | 181.30M |
|
| Revenues (USD) | 181.30M |
| Cost of Revenue | 37.83M |
| Gross Profit | 143.47M |
| Operating Expenses | 123.48M |
| Research and Development Expense | 19.04M |
| Selling, General and Administrative Expense | 66.52M |
| Operating Income | 19.99M |
| Interest Expense | 15.63M |
| Income Tax Expense | 434.00K |
| Net Income | 3.92M |
| Net Income Common Stock | 3.92M |
| Net Income Common Stock (USD) | 3.92M |
| Consolidated Income | 3.92M |
| Earnings per Basic Share | 0.05 |
| Earnings per Basic Share (USD) | 0.05 |
| Earnings per Diluted Share | 0.04 |
| Earning Before Interest & Taxes (EBIT) | 19.99M |
| Earning Before Interest & Taxes (USD) | 19.99M |
| Weighted Average Shares | 86.43M |
| Weighted Average Shares Diluted | 89.79M |
| Balance Sheet |
| Cash and Equivalents | 712.53M |
| Cash and Equivalents (USD) | 712.53M |
| Trade and Non-Trade Receivables | 183.53M |
| Current Assets | 1.03B |
| Property, Plant & Equipment Net | 153.60M |
| Total Assets | 2.20B |
| Total Debt | 951.55M |
| Current Liabilities | 955.70M |
| Debt Non-Current | 951.55M |
| Total Liabilities | 1.94B |
| Accumulated Retained Earnings (Deficit) | 81.67M |
| Accumulated Other Comprehensive Income | -6.81M |
| Shareholders Equity | 264.20M |
| Shareholders Equity (USD) | 264.20M |
| Assets Non-Current | 1.18B |
| Total Debt (USD) | 951.55M |
| Goodwill and Intangible Assets | 950.05M |
| Inventory | 69.66M |
| Liabilities Non-Current | 984.16M |
| Trade and Non-Trade Payables | 226.32M |
| Tax Assets | 4.55M |
| Tax Liabilities | 6.51M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 39.49M |
| Net Cash Flow from Financing | 512.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | 312.63M |
| Capital Expenditure | -30.75M |
| Issuance (Purchase) of Equity Shares | 520.00K |
| Net Cash Flow from Investing | -30.75M |
| Net Cash Flow from Operations | 342.25M |
| Effect of Exchange Rate Changes on Cash | 612.00K |
| Share Based Compensation | 3.23M |